Form 4: Inotiv Inc. Executive John E. Sagartz Reports Stock and Option Awards

John E. Sagartz, Chief Strategy Officer of Inotiv, Inc., reports the acquisition of 20,000 shares of common stock and an option to purchase 20,000 shares, both awarded on August 10, 2024.

Summary

• On August 10, 2024, John E. Sagartz, Chief Strategy Officer of Inotiv, Inc., was granted 20,000 shares of common stock.
• These shares are restricted stock units that will vest in full on June 18, 2026, contingent upon continued employment.
• Sagartz also received an option to purchase 20,000 shares of Inotiv's common stock at an exercise price of $1.61.
• The stock option vests over three years: 40% on June 18, 2025, 30% on June 18, 2026, and 30% on June 18, 2027, also subject to continued employment.
• Following these transactions, Sagartz directly owns 712,047 shares of Inotiv common stock and options for 20,000 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of executive compensation, which is neither particularly positive nor negative.

Positives

• The grant of restricted stock units and stock options to a key executive like the Chief Strategy Officer suggests an incentive to align their interests with the long-term success of the company.
• The vesting schedules tied to continued employment encourage the executive's continued service and contribution to Inotiv.

Future Outlook

The vesting schedules for the stock and options suggest a focus on long-term performance and retention of the executive.

Industry Context

Stock and option awards are a common practice in the biotech and pharmaceutical services industry to incentivize executives and align their interests with shareholder value. These awards are typically structured with vesting schedules to encourage long-term commitment.

Comparison to Industry Standards

• Companies like Charles River Laboratories and Envigo (now part of Inotiv) also use stock options and restricted stock units as part of their executive compensation packages.
• The vesting schedules are fairly standard, with many companies using threeto four-year vesting periods for stock options and restricted stock units.
• The specific amounts and terms of the awards would need to be compared to peer companies to determine if they are in line with industry norms.

Stakeholder Impact

• Shareholders may view the stock and option awards as a positive sign, indicating that management's interests are aligned with theirs.
• Employees may see this as a positive sign of investment in the company's leadership.

Key Dates